Click here to view the Humana Medical Policy Updates Updates » January 2025 Humana Medical…
BCBS Louisiana Medical Policy Updates – February 2019
February 2019 BCBS Louisiana Medical Policy Updates:
- abatacept (Orencia)
- Advanced Therapies for Pharmacological Treatment of Pulmonary Hypertension
- alemtuzumab (Lemtrada)
- Allogeneic Pancreas Transplant
- Ambulatory Blood Pressure Monitoring – Archived Policy
- Amnioreduction and/or Fetoscopic Laser Therapy for Twin-Twin Transfusion Syndrome – Archived Policy
- Assays of Genetic Expression in Tumor Tissue as a Technique to Determine Prognosis in Patients with Breast Cancer
- Branded Bupropion Products
- Breast Brachytherapy
- C1 Esterase Inhibitor (Cinryze, Haegarda)
- Cooling Devices Used in the Outpatient Setting
- Dopamine Transporter Imaging With Single-Photon Emission Computed Tomography
- Electrical Nerve Stimulation Devices
- Endoscopic Radiofrequency Ablation or Cryoablation for Barrett’s Esophagus
- Genetic Testing for Cardiac Ion Channelopathies
- Genetic Testing for FLT3, NPM1, and CEBPA Variants in Cytogenetically Normal Acute Myeloid Leukemia
- Genetic Testing for Hereditary Breast and/or Ovarian Cancer Syndrome (BRCA1/BRCA2)
- Image-Guided Minimally Invasive Decompression for Spinal Stenosis
- Injectable Clostridial Collagenase for Fibroproliferative Disorders
- Interim Positron Emission Tomography Scanning in Oncology to Detect Early Response During Treatment
- Medical Management of Obstructive Sleep Apnea Syndrome
- Microarray-Based Gene Expression Profile Testing for Multiple Myeloma Risk Stratification
- Minimally Invasive Treatment of Nasal Valve Collapse
- Molecular Testing for the Management of Pancreatic Cysts or Barrett Esophagus
- natalizumab (Tysabri)
- Omega-3 Fatty Acid Products
- Ophthalmologic Techniques That Evaluate the Posterior Segment for Glaucoma
- pegloticase (Krystexxa)
- Pharmacotherapy for Idiopathic Pulmonary Fibrosis
- Plugs for Anal Fistula Repair
- Positron Emission Tomography (PET) Oncology Applications
- Radiofrequency Ablation of Peripheral Nerves to Treat Pain
- Select Oral Oncology Drugs
- Stereotactic Radiosurgery and Stereotactic Body Radiotherapy
- Syndros (dronabinol)
- Systems Pathology in Prostate Cancer
- Total Parenteral Nutrition and Enteral Nutrition in the Home
- Transanal Radiofrequency Treatment of Fecal Incontinence
- Treatment of Hepatitis C with Dual Therapy (Ribavirin Plus Pegylated Interferon Alfa)-Archived Medical Policy
- Treatment of Varicose Veins/Venous Insufficiency
- Vesicular Monoamine Transporter Type 2 Inhibitors: deutetrabenazine (Austedo), tetrabenazine (Xenazine), valbenazine (Ingrezza)
- Virtual Colonoscopy/CT Colonography
- Xadago (safinamide)
- Xatmep (methotrexate oral solution)
- Zurampic, Duzallo (lesinurad Products)
Click here to view the Blue Cross Blue Shield Louisiana Medical Policy Updates »
Policy Alerts monitors Commercial and Medicare medical policies for changes. While medical Insurance carriers typically update medical policies annually, there are many reasons why they might review or update a policy. When reviews occur out of cycle they often go unnoticed. Policy Alerts keeps you updated when Payers make coverage changes to medical policies affecting your business.
Policy Alerts continuously monitors Commercial and Medicare Payer coverage information to keep you up-to-date on medical Insurance decisions in real-time. When changes occur, instant email alerts are delivered to your inbox. Clients have access to detailed coverage reports and medical policies through the interactive Policy Alerts Dashboard portal. Save time each month and keep focused on important Payer medical policy reviews and coverage decisions affecting your business!
Policy Alerts takes a client-focused hands-on approach and is constantly working to provide our customers with helpful insights and actionable analytics. We understand what our clients need and are dedicated to providing timely, accurate, and always up-to-date reports.
Health economic and reimbursement information provided by Policy Alerts is gathered from third-party sources and is subject to change without notice as a result of complex and frequently changing laws, regulations, rules and policies. All product and company names are trademarks™ or registered® trademarks of their respective holders. Use of them does not imply any affiliation with or endorsement by them. This information is presented for illustrative purposes only and does not constitute reimbursement or legal advice.